Article
Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth
30 Dec 2016
Abstract excerpt
Abstract Senescent cells within the tumor microenvironment (TME) adopt a proinflammatory, senescence-associated secretory phenotype (SASP) that promotes cancer initiation, progression, and therapeutic resistance. Here, exposure to palbociclib (PD-0332991), a CDK4/6 inhibitor, induces senescence and a robust SASP in normal fibroblasts. Senescence caused by prolonged CDK4/6 inhibition is DNA damage–independent and...
Topics
Join the communities discussing this publication.